Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$16.3M
-4.8% from 2023
Prescriptions
251K
$64.98 per claim
Patients
102K
63,480 prescribers
Total spending, 2024
$16.3M
$160.14 per patient
Medicare prescription drug plans paid $16.3M for Levalbuterol Tartrate Hfa in 2024, for 251,484 prescriptions and refills to 102,046 patients (down 4.8% from 2023). The average cost per claim was $64.98.
California had the highest Medicare cost for Levalbuterol Tartrate Hfa in 2024: $1.6M for 24,798 claims, followed by Florida ($1.3M).
Jorge Sanchez-Masiques, pulmonary disease in Miami, FL, had the highest Medicare cost for Levalbuterol Tartrate Hfa in 2024: 1,223 claims costing $61K.
Levalbuterol Tartrate Hfa is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Actavis/Teva.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 1,223 | 298 | $61K |
| Adriana Arcila Manati, PR | Internal Medicine | 686 | 159 | $42K |
| Luis F Nieves Garrastegui |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 52,729 | 201,041 | 76,605 | $14.8M |
| 2023 | 60,900 | 243,839 | 92,981 | $17.2M |
| 2024 | 63,480 | 251,484 | 102,046 | $16.3M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 651 |
| 373 |
| $38K |
| Irina Zolotarevskaya Rego Park, NY | Pulmonary Disease | 478 | 118 | $36K |
| Miriam Martinez-Torres Cayey, PR | Pulmonary Disease | 615 | 158 | $35K |
| Carissa M Cruz Berrios Humacao, PR | Internal Medicine | 486 | 156 | $31K |
| Lisandra Perez Colon Ponce, PR | Pulmonary Disease | 455 | 121 | $27K |
| Pedro J Monroig Quiles San Juan, PR | Internal Medicine | 342 | 114 | $21K |
| Rosa I Roman Carlo Mayaguez, PR | Pulmonary Disease | 330 | 63 | $20K |
| Armando O Cardona-Ramirez Mayaguez, PR | Pulmonary Disease | 219 | 64 | $19K |
| Glorimar Santos Fajardo, PR | Pulmonary Disease | 307 | 145 | $18K |
| Zulfiqar Ahmed Glendale, CA | Pulmonary Disease | 246 | 67 | $15K |
| Olusegun A Oseni Weatherford, TX | Pulmonary Disease | 249 | 140 | $15K |
| Mildred Caro Ruiz Aguada, PR | Pulmonary Disease | 217 | 64 | $13K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 152 | 77 | $13K |
| Francisco M Montalvo Mayaguez, PR | Pulmonary Disease | 207 | 46 | $13K |
| Ruben Rodriguez-Perez Sr. San Juan, PR | Pulmonary Disease | 198 | 80 | $12K |
| Louis E Steinberg College Park, MD | Pulmonary Disease | 117 | 53 | $11K |
| Elsie M Diaz - Schroeder Caguas, PR | Pulmonary Disease | 185 | 47 | $11K |
| Carlos R Garcia Rodriguez San Juan, PR | Pulmonary Disease | 184 | 70 | $11K |
| Gurprakash S Grewal Saint Louis, MO | Family Practice | 161 | 19 | $11K |
| Jesse R Aleman-Ortiz Trujillo Alto, PR | Pulmonary Disease | 163 | 36 | $10K |
| Samer Alkhuja East Stroudsburg, PA | Pulmonary Disease | 120 | 48 | $9,930 |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 162 | 62 | $9,366 |
| Evelyn Ramirez Zapata San Juan, PR | Pulmonary Disease | 163 | 71 | $9,167 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Actavis/Teva TEVA | 251,600 | $16.3M |